Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast Cancer von Samuel Eziokwu, Akaolisa, Varella, Leticia, Lynn Kruse, Megan, Jia, Xuefei, Moore, Halle C.F., Thomas Budd, George, Abraham, Jame, Montero, Alberto J.

Volltext

Use of chemotherapy for patients with bone and soft-tissue sarcomas von Wesolowski, Robert, Budd, George Thomas

Volltext

A 33-Year-Old Man With Multiple Bilateral Pulmonary Pseudoaneurysms von Rokadia, Haala K., MD, Heresi, Gustavo A., MD, Tan, Carmela D., MD, Raymond, Daniel P., MD, Budd, George Thomas, MD, Farver, Carol, MD

Volltext

Phase I trial of weekly docetaxel, weekly doxorubicin, daily oral cyclophosphamide, and G-CSF (ConTAC Regimen)in advanced malignancies von Wesolowski, Robert, Peereboom, David, Weiss, Patricia, Elson, Paul, Thomas Budd, George

Volltext

Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy von Varella, Leticia, Eziokwu, Akaolisa Samuel, Jia, Xuefei, Kruse, Megan, Moore, Halle C. F., Budd, George Thomas, Abraham, Jame, Montero, Alberto J.

Volltext

Phase I trial of an alpha-lactalbumin vaccine in patients with moderate- to high-risk operable triple-negative breast cancer (TNBC) von Budd, George Thomas, Johnson, Justin M., Esakov Rhoades, Emily, Moore, Halle C. F., Kruse, Megan Lynn, Roesch, Erin Elizabeth, Abraham, Jame, Elliott, Brenna, Lach, Donna, Tuohy, Vincent K.

Volltext

Vitamin D insufficiency as a peripheral neuropathy risk factor in white and black patients in SWOG 0221 von Chen, Ciao-Sin Chelsea, Zirpoli, Gary, McCann, Susan, Barlow, William E., Budd, George Thomas, Pusztai, Lajos, Hortobagyi, Gabriel N., Godwin, Andrew K., Thompson, Alastair Mark, Ambrosone, Christine B., Stringer, Kathleen A, Hertz, Daniel Louis

Volltext

Estimates of stage-specific preclinical sojourn time across 21 cancer types von Broder, Michael S., Ailawadhi, Sikander, Beltran, Himisha, Blakely, L. Johnetta, Budd, George Thomas, Carr, Laurie, Cecchini, Michael, Cobb, Patrick Wayne, Gibbs, Sarah N., Kansal, Anuraag, Kim, Ashley, Monk, Bradley J., Schwartzberg, Lee S., Wong, Deborah J.L., Yermilov, Irina

Volltext

Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer von Sharifi, Nima, Kruse, Megan Lynn, McManus, Jeffrey, Chung, Yoon-Mi, Wei, Wei, Bazeley, Peter, Nakamura, Fumihiko, Hardaway, Aimalie, Downs Kelley, Erinn, Chandarlapaty, Sarat, Thomas, Mathew, Moore, Halle C. F., Budd, George Thomas, Tang, Wai Hong Wilson, Hazen, Stanley L., Bernstein, Aaron, Nik-Zainal, Serena, Abraham, Jame

Volltext

Real-world evidence evaluating continuation of CDK4/6 inhibitors beyond first progression in hormone receptor-positive (HR+) metastatic breast cancer von Eziokwu, Akaolisa Samuel, Varella, Leticia, Kruse, Megan Lynn, Jia, Xuefei, Moore, Halle C. F., Budd, George Thomas, Abraham, Jame, Montero, Alberto J.

Volltext

Safety and unique pharmacokinetic profile of ARX788, a site-specific ADC, in heavily pretreated patients with HER2-overexpresing solid tumors: Results from two phase 1 clinical tri... von Hurvitz, Sara A., Park, Haeseong, Frentzas, Sophia, Shannon, Catherine M., Cuff, Katharine, Eek, Richard Wilhelm, Budd, George Thomas, McCartney, Amelia, O'Shaughnessy, Joyce, Lu, Janice M., Zhang, Jian, Ji, Dongmei, Shen, Weina, Li, Matt, Yan, Jinchun, Xia, Gang, Ji, Yanping, Yao, Sulan, Xiong, Gaozhun, Hu, Xichun

Volltext

Real world clinical outcomes of palbociclib in hormone receptor positive (HR+) metastatic breast cancer (MBC) patients von Eziokwu, Akaolisa Samuel, Varella, Leticia, Kruse, Megan Lynn, Jia, Xuefei, Moore, Halle C. F., Budd, George Thomas, Abraham, Jame, Montero, Alberto J.

Volltext

Longitudinal precision oncology experience in solid tumors at the Cleveland Clinic von Sadaps, Meena, Funchain, Pauline, Mahdi, Haider, Grivas, Petros, Pritchard, Amy, Klek, Stefan, Estfan, Bassam N., Abraham, Jame, Budd, George Thomas, Stevenson, James, Pennell, Nathan A., Khorana, Alok A., Bolwell, Brian James, Sohal, Davendra

Volltext

Abstract 3035: Phase I trial of alpha-lactalbumin vaccine in high-risk operable triple-negative breast cancer von Budd, George Thomas, Johnson, Justin M., Rhoades, Emily, Moore, Halle, Levengood, Holly, Kruse, Megan, Roesch, Erin, Abraham, Jame, Elliott, Brenna, Haury, Elena, Swartz, Rachel, Pederson, Holly, Hilli, Zahraa Al, Tuohy, Vincent

Volltext

Adjuvant therapy of osteosarcoma—A Phase II trial von Zalupski, Mark M., Rankin, Cathryn, Ryan, James R., Lucas, David R., Muler, Jeffrey, Lanier, Keith S., Budd, George Thomas, Biermann, J. Sybil, Meyers, Frederick J., Antman, Karen

Volltext

A young woman with a breast mass: What every internist should know von Wesolowski, Robert, Budd, George Thomas

Volltext

Association between biologically effective dose and local control after stereotactic body radiotherapy for metastatic sarcoma von Somasundaram, Eashwar, D Smile, Timothy, Halima, Ahmed, Broughman, James B, Reddy, Chandana A, Parsai, Shireen, Scott, Jacob G, Shah, Chirag, Chan, Timothy, Campbell, Shauna, Angelov, Lilyana, Anderson, Peter M, Zahler, Stacy, Trucco, Matteo, Thomas, Stefanie M, Johnson, Shavaughn, Mesko, Nathan, Nystrom, Lukas, Shepard, Dale, Budd, George Thomas, Qi, Peng, Magnelli, Anthony, Murphy, Erin S

Volltext

Neoadjuvant therapy for breast cancer: Assessing treatment progress and managing poor responders von Wesolowski, Robert, Budd, George Thomas

Volltext

Fluorescence In Situ Hybridization (FISH) as Primary Methodology for the Assessment of HER2 Status in Adenocarcinoma of the Breast: A Single Institution Experience von Tubbs, Raymond R, Hicks, David G, Cook, James, Downs-Kelly, Erinn, Pettay, James, Hartke, Mary Beth, Hood, LaShonda, Neelon, Rosemary, Myles, Jonathan, Budd, George Thomas, Moore, Halle C, Andresen, Steve, Crowe, Joseph P

Volltext

Neoadjuvant therapy for breast cancer: Assessing treatment progress and managing poor responders von Wesolowski, Robert, Budd, George Thomas

Volltext